Free Trial

Evaxion Biotech A/S (EVAX) News Today

Evaxion Biotech A/S logo
$1.67 -0.02 (-1.40%)
As of 12:37 PM Eastern
Evaxion Biotech reports Q4 EPS (7c) vs (17c) last year
Q4 2024 Evaxion Biotech A/S Earnings Call
Q4 2024 Evaxion Biotech A/S Earnings Call Transcript
Evaxion Biotech A/S (EVAX) Q4 2024 Earnings Call Transcript
Evaxion announces business update and full year 2024 financial results
A Glimpse of Evaxion Biotech's Earnings Potential
Agillic appoints new CFO Jack Sørensen
Evaxion Biotech files $50M ordinary shares offering
Evaxion to present at numerous upcoming conferences
EVAX Adds to Trial Due to Excellent Results
Evaxion Biotech re-established compliance with Nasdaq
Evaxion Biotech (EVAX) Receives a Buy from Lake Street
Evaxion Biotech price target lowered to $6 from $35 at Lake Street
Evaxion Biotech prices 3.997M ADSs at $2.71 in public ofering
Evaxion Biotech prices 3.997M ADSs at $2.71 in public ofering
Evaxion Biotech granted 180-day compliance extension by Nasdaq
Evaxion Biotech completes dosing in phase 2 trial with EVX-01
Evaxion announces completion of ADS ratio change
Evaxion Biotech trading halted, news pending
Remove Ads
Get Evaxion Biotech A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.

EVAX Media Mentions By Week

EVAX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EVAX
News Sentiment

0.44

0.57

Average
Medical
News Sentiment

EVAX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EVAX Articles
This Week

12

2

EVAX Articles
Average Week

Remove Ads
Get Evaxion Biotech A/S News Delivered to You Automatically

Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:EVAX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners